Literature DB >> 17003480

Hepatitis B virus promotes angiopoietin-2 expression in liver tissue: role of HBV x protein.

Paloma Sanz-Cameno1, Samuel Martín-Vílchez, Enrique Lara-Pezzi, María J Borque, Javier Salmerón, Paloma Muñoz de Rueda, José A Solís, Manuel López-Cabrera, Ricardo Moreno-Otero.   

Abstract

The progression of chronic hepatitis B (CHB) is related to fibrosis and to the emergence of intrahepatic anomalous vascular structures. Hepatitis B virus (HBV) X protein transactivator (HBx) may play a significant role in both processes. To analyze how HBV induces vascular growth and remodeling in vivo, we assessed the expression of angiopoietin-2 (Ang2) in liver biopsies from CHB patients by reverse transcriptase-polymerase chain reaction, Western blotting, and immunohistochemistry because of the relevant role of Ang2 in vascular development, remodeling, and tumor promotion. In addition, we analyzed the influence of HBx in the expression of Ang2 in HBx-expressing hepatocyte cell lines and in hepatic stellate cells stimulated with conditional medium from HBx-hepatocytes. Ang2 expression was clearly up-regulated at both mRNA and protein levels in the liver of CHB patients, showing an intense staining of inflammatory infiltrates and vascular structures at inflamed portal areas. HBx-expressing hepatocytes and stimulated stellate cells showed a significant induction of Ang2 expression. PI3K inhibitor and antioxidants repressed the 64-kd Ang2 form but further enhanced the inflammation-related 50-kd molecular species. Therefore, HBx could account for the induction of Ang2 observed in CHB, especially the 50-kd form, contributing to pathological angiogenesis and hepatocellular carcinoma progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003480      PMCID: PMC1698851          DOI: 10.2353/ajpath.2006.051246

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

1.  Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188.

Authors:  P Carmeliet; Y S Ng; D Nuyens; G Theilmeier; K Brusselmans; I Cornelissen; E Ehler; V V Kakkar; I Stalmans; V Mattot; J C Perriard; M Dewerchin; W Flameng; A Nagy; F Lupu; L Moons; D Collen; P A D'Amore; D T Shima
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study.

Authors:  Jesús Medina; Paloma Sanz-Cameno; Luisa García-Buey; Samuel Martín-Vílchez; Manuel López-Cabrera; Ricardo Moreno-Otero
Journal:  J Hepatol       Date:  2005-01       Impact factor: 25.083

3.  Induction of angiopoietin-2 gene expression by COX-2: a novel role for COX-2 inhibitors during hepatocarcinogenesis.

Authors:  Shinji Tanaka; Jack R Wands; Shigeki Arii
Journal:  J Hepatol       Date:  2005-11-02       Impact factor: 25.083

4.  Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma.

Authors:  Francesca Cerimele; Traci Battle; Rebecca Lynch; David A Frank; Emma Murad; Cynthia Cohen; Nada Macaron; John Sixbey; Kenneth Smith; Randolph S Watnick; Aristidis Eliopoulos; Bahig Shehata; Jack L Arbiser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

5.  Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells.

Authors:  V Ankoma-Sey; Y Wang; Z Dai
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

Review 6.  Hepatocellular carcinoma.

Authors:  D F Schafer; M F Sorrell
Journal:  Lancet       Date:  1999-04-10       Impact factor: 79.321

7.  Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

Authors:  J Holash; P C Maisonpierre; D Compton; P Boland; C R Alexander; D Zagzag; G D Yancopoulos; S J Wiegand
Journal:  Science       Date:  1999-06-18       Impact factor: 47.728

Review 8.  Liver fibrosis.

Authors:  Ramón Bataller; David A Brenner
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

9.  Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.

Authors:  T Asahara; D Chen; T Takahashi; K Fujikawa; M Kearney; M Magner; G D Yancopoulos; J M Isner
Journal:  Circ Res       Date:  1998-08-10       Impact factor: 17.367

10.  Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation.

Authors:  Ulrike Fiedler; Yvonne Reiss; Marion Scharpfenecker; Verena Grunow; Stefanie Koidl; Gavin Thurston; Nicholas W Gale; Martin Witzenrath; Simone Rosseau; Norbert Suttorp; Astrid Sobke; Matthias Herrmann; Klaus T Preissner; Peter Vajkoczy; Hellmut G Augustin
Journal:  Nat Med       Date:  2006-02-05       Impact factor: 53.440

View more
  20 in total

Review 1.  Potential mechanisms of hepatitis B virus induced liver injury.

Authors:  Mohd Suhail; Hany Abdel-Hafiz; Ashraf Ali; Kaneez Fatima; Ghazi A Damanhouri; Esam Azhar; Adeel Ga Chaudhary; Ishtiaq Qadri
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

2.  Regulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: integrated GWRS and GWGS analyses.

Authors:  Xu Zhou; Hua-Qiang Zhu; Jun Lu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

3.  Interaction of mutant hepatitis B X protein with p53 tumor suppressor protein affects both transcription and cell survival.

Authors:  Shoba Iyer; John D Groopman
Journal:  Mol Carcinog       Date:  2011-03-22       Impact factor: 4.784

4.  Angiogenesis: from chronic liver inflammation to hepatocellular carcinoma.

Authors:  Paloma Sanz-Cameno; María Trapero-Marugán; María Chaparro; Evan Anthony Jones; Ricardo Moreno-Otero
Journal:  J Oncol       Date:  2010-05-27       Impact factor: 4.375

Review 5.  Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma.

Authors:  Alla Arzumanyan; Helena M G P V Reis; Mark A Feitelson
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

Review 6.  Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.

Authors:  Mark A Feitelson; Helena M G P V Reis; N Lale Tufan; Bill Sun; Jingbo Pan; Zhaorui Lian
Journal:  Cancer Lett       Date:  2009-02-06       Impact factor: 8.679

Review 7.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

Review 8.  Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis.

Authors:  Mirko Tarocchi; Simone Polvani; Giada Marroncini; Andrea Galli
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 9.  The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.

Authors:  Silvia Affo; Le-Xing Yu; Robert F Schwabe
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

Review 10.  Targeting NADPH oxidases for the treatment of cancer and inflammation.

Authors:  Michael Y Bonner; Jack L Arbiser
Journal:  Cell Mol Life Sci       Date:  2012-05-13       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.